Prv (159)

has unveiled study that show its experimental allergy drug, an improved version of Johnson & Johnson's Hismanal, appears stronger than Schering Plough Corp.'s best seller Claritin. The findings, posted Monday on the company's Web site and reviewed in a conference call, are intended to reassure investors about the drug's potential after Johnson & Johnson on Friday scrapped... . Fort Worth Star Telegram , The joys of spring burst forth Seasonal allergy woes return Allergy sufferers don't need a calendar to tell them that spring arrives at p.m. today Their noses have already alerted them. No sooner did mountain cedar sufferers recover from what allergists describe as one of the worst onsl hts in recent years than blew in with oak, elm, mulberry and hackberry. Add these pollens to the already polluted North Texas skies and it's enough to make anyone sneeze."Springtime is always bad," said... . St. Louis Post Dispatch May , MEDICAL COMPANY ISSUES WORLDWIDE RECALL FOR INJECTORS USED TO FIGHT ALLERGY ATTACKS A yland medical company issued an urgent international recall Friday of about million devices called the EpiPen and EpiPen Jr. that allergy sufferers carry to treat life threatening attacks.Certain batches of the pen size injector full of epinephrine may not contain enough of the drug to work during an acute attack, said the company, Meridian Medical Technologies Inc. The company does not know of any patient who has been hurt by the ineffective injectors, which it discovered during a... . The Record (New Jersey) , NOTHING TO SNEEZE AT CASHING IN ON ALLERGY SUFFERERS Allergy season is starting early this year, and it's bringing with it waves of advertising as pharmaceutical companies triple their ad budgets to compete in the $ . billion ket for allergy drugs. Most of the estimated million Americans suffering from seasonal allergies do not seek treatment, and drug makers are eager to win them over.The allergy ads are part of a trend in which the pharmaceutical industry is aiming more of its messages directly at consumers rather than... . Los Angeles Times , Drug Makers Aiming Straight for Consumers' Watery Eyes Allergy drug makers have an unusual ally this year as they launch their spring advertising campaigns El Nino.Soggy conditions courtesy of the weather pattern have increased pollen and mold counts, heightening the misery of the estimated million people in the U.S. who are fighting seasonal allergies. And more sneezing and watery eyes means potentially greater sales for prescription allergy remedies Claritin, Allegra and Zyrtec, as they enter their first spring season with loosened rules... . Morning Call, The (Allentown, PA) , EASTON RESTAURANT TO HOLD FOOD ALLERGY SEMINAR Restaurant owners, chefs, wait staff, and anybody who feeds anybody from church groups, hotel personnel and shelter managers are invited to a food allergy seminar at p.m. Monday at Pearly Baker's Ale House, Center Square, Easton.Conducting the seminar will be Debra Indorato, registered dietitian and medical nutrition counselor who works with Dr. k Shampain of Allentown. She'll hand out information and show slides and a video during her presentation.... . USA TODAY , FDA plans to pull allergy drug Seldane The Food and Drug Administration said Monday it is moving to take Seldane, an allergy drug prescribed by d ors more than million times last year, off the ket. It has been known since that Seldane and Seldane D can cause dangerous heart problems when taken at the same time as the antibiotic erythromycin or the antifungal drug ketoconozole.The FDA has received reports of serious cardiac problems, including deaths, associated with Seldane.But the approval of a safer... . THE SAN FRANCISCO CHRONICLE , FDA Moves To Ban an Allergy Drug Safer alternative to Seldane available The Food and Drug Administration moved yesterday to ban sales of the popular prescription allergy drug Seldane, which has been linked to potentially fatal heart problems when taken with some other drugs.

Ind